Claritas HealthTech Commences Clinical Validation For CystoSmart™ An AI Tool For Bladder Cancer Detection

LONDON and SINGAPORE, Dec 1 (Bernama-GLOBE NEWSWIRE) —Claritas HealthTech (“Claritas”), a healthcare technology company specializing in medical image enhancement and Artificial Intelligence (AI) assisted diagnostic tools, announces today that it is commencing clinical validation of CystoSmart™. CystoSmart™ is an image enhancement and AI diagnostic tool for bladder cancer detection in images (videos and camera stream) seen on white light cystoscopy and narrow band imaging (NBI) cystoscopy.

CystoSmart™, a Software as a Medical Device (SaMD), has been jointly developed through a research collaboration between Claritas and Khoo Teck Puat Hospital (KTPH), Singapore, under the leadership of Dr. Yeow Siying.

http://mrem.bernama.com/viewsm.php?idm=44889

administrator

Related Articles